Quotient Limited - Ordinary Shares (QTNT): Price and Financial Metrics


Quotient Limited - Ordinary Shares (QTNT): $2.90

0.06 (+2.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

QTNT POWR Grades


  • QTNT scores best on the Momentum dimension, with a Momentum rank ahead of 51.62% of US stocks.
  • The strongest trend for QTNT is in Growth, which has been heading down over the past 47 weeks.
  • QTNT ranks lowest in Growth; there it ranks in the 24th percentile.

QTNT Stock Summary

  • Quotient Ltd's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 3.92% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -25.75 for Quotient Ltd; that's greater than it is for just 0.89% of US stocks.
  • Quotient Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -58.39%, greater than the shareholder yield of just 4.35% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Quotient Ltd are RDUS, PROF, HSTO, GPL, and MOSY.
  • QTNT's SEC filings can be seen here. And to visit Quotient Ltd's official web site, go to quotientbd.com.

QTNT Valuation Summary

  • In comparison to the median Healthcare stock, QTNT's price/earnings ratio is 107.95% lower, now standing at -2.9.
  • Over the past 90 months, QTNT's price/sales ratio has gone down 0.3.
  • Over the past 90 months, QTNT's price/earnings ratio has gone up 19.8.

Below are key valuation metrics over time for QTNT.

Stock Date P/S P/B P/E EV/EBIT
QTNT 2021-08-31 7.2 -6.0 -2.9 -5.5
QTNT 2021-08-30 7.1 -6.0 -2.9 -5.4
QTNT 2021-08-27 7.2 -6.1 -2.9 -5.5
QTNT 2021-08-26 7.0 -5.9 -2.9 -5.4
QTNT 2021-08-25 7.5 -6.3 -3.0 -5.6
QTNT 2021-08-24 7.8 -6.6 -3.2 -5.8

QTNT Growth Metrics

  • The 4 year price growth rate now stands at -39.09%.
  • Its 4 year net income to common stockholders growth rate is now at -203.36%.
  • Its year over year cash and equivalents growth rate is now at 322.7%.
Over the past 52 months, QTNT's revenue has gone up $21,317,000.

The table below shows QTNT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 43.544 -84.827 -107.439
2021-03-31 43.379 -77.582 -108.47
2020-12-31 42.441 -72.626 -94.888
2020-09-30 41.631 -68.561 -92.616
2020-06-30 33.411 -80.4 -104.631
2020-03-31 32.656 -80.646 -102.773

QTNT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • QTNT has a Quality Grade of C, ranking ahead of 29.16% of graded US stocks.
  • QTNT's asset turnover comes in at 0.172 -- ranking 211th of 677 Pharmaceutical Products stocks.
  • BMRN, RGNX, and PTGX are the stocks whose asset turnover ratios are most correlated with QTNT.

The table below shows QTNT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.172 0.542 -0.240
2021-03-31 0.185 0.537 -0.234
2020-12-31 0.180 0.538 -0.193
2020-09-30 0.176 0.539 -0.188
2020-06-30 0.157 0.442 -0.230
2020-03-31 0.155 0.455 -0.227

QTNT Price Target

For more insight on analysts targets of QTNT, see our QTNT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.38 Average Broker Recommendation 1.38 (Strong Buy)

QTNT Stock Price Chart Interactive Chart >

Price chart for QTNT

QTNT Price/Volume Stats

Current price $2.90 52-week high $7.59
Prev. close $2.84 52-week low $2.63
Day low $2.79 Volume 2,531,800
Day high $3.04 Avg. volume 629,747
50-day MA $3.18 Dividend yield N/A
200-day MA $4.33 Market Cap 294.61M

Quotient Limited - Ordinary Shares (QTNT) Company Bio


Quotient Limited develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company was founded in 2007 and is based in Penicuik, the United Kingdom.


QTNT Latest News Stream


Event/Time News Detail
Loading, please wait...

QTNT Latest Social Stream


Loading social stream, please wait...

View Full QTNT Social Stream

Latest QTNT News From Around the Web

Below are the latest news stories about Quotient Ltd that investors may wish to consider to help them evaluate QTNT as an investment opportunity.

Quotient Limited Announces Christian Albrich as Chief People Officer

JERSEY, Channel Islands, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that Christian Albrich has been appointed as Chief People Officer of the Company and will begin serving in that role as of today.

Intrado Digital Media | September 1, 2021

Even after rising 13% this past week, Quotient (NASDAQ:QTNT) shareholders are still down 59% over the past three years

Quotient Limited ( NASDAQ:QTNT ) shareholders should be happy to see the share price up 13% in the last week. But that...

Yahoo | August 26, 2021

Quotients CEO, Steven Boal, to Speak on Quotient and Digital Advertising on an Educational Series Investor Call Hosted by UBS

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $QUOT #consumer--Quotients CEO, Steven Boal, to Speak on Quotient and Digital Advertising on an Educational Series Investor Call hosted by UBS

Business Wire | August 12, 2021

Quotient Limited Announces Departure of Chief Commercial Officer, Jeremy Stackawitz

JERSEY, Channel Islands, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Jeremy Stackawitz has notified the Company that he is resigning from his position as Chief Commercial Officer.

Intrado Digital Media | August 11, 2021

Quotient Limited Provides First Quarter Fiscal 2022 Results and Business Update

JERSEY, Channel Islands, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its first quarter fiscal 2022 key achievements and summarized recent business developments.

Intrado Digital Media | August 5, 2021

Read More 'QTNT' Stories Here

QTNT Price Returns

1-mo 2.47%
3-mo -27.50%
6-mo -20.98%
1-year -48.76%
3-year -56.46%
5-year -63.29%
YTD -44.34%
2020 -45.22%
2019 55.39%
2018 23.64%
2017 2.27%
2016 -69.75%

Continue Researching QTNT

Want to see what other sources are saying about Quotient Ltd's financials and stock price? Try the links below:

Quotient Ltd (QTNT) Stock Price | Nasdaq
Quotient Ltd (QTNT) Stock Quote, History and News - Yahoo Finance
Quotient Ltd (QTNT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8564 seconds.